Literature DB >> 17010401

Urinary free cortisol and cortisone excretion in healthy individuals: influence of water loading.

Martin Fenske1.   

Abstract

The influence of water loading on urinary excretion of free cortisol and cortisone was investigated in healthy men. The results were as follows: water loading tests (intake of 0.25-1.5 L) in a single individual showed that a water load of 1.5 L reliably increased the excretion of urine, free cortisol and cortisone (p < 0.01). Regression analyses gave significant correlations of urine volume with free cortisol and free cortisone, and of free cortisol and free cortisone. Corresponding results were obtained when water loading tests were performed in males who ingested 1.5 L of water (n = 8): the excretion of urine, free cortisol and free cortisone were significantly augmented; correlated was urine volume with free cortisol and free cortisone, and free cortisol with free cortisone. In a third set of tests, volunteers collected one 5 h urine (10:00-15:00 h) after the intake of 3 x 0.1 or 0.5 L at 11:00, 12:00 and 14:00 h. Excretion of urine, free cortisol and free cortisone in males of the low water loading group (3 x 0.1 L) was 0.59 mL/min, and 8.2 or 15.0 microg/5 h; corresponding values in individuals ingesting 3 x 0.5 L of water were 1.5 mL/min (p < 0.01), 12.3 microg/5 h (p > 0.05) and 26.3 microg/5 h (p < 0.02). In summary, urinary free cortisol and cortisone excretion in healthy men depends on urine volume, especially during water diuresis. Thus, interpretation of free cortisol and especially of free cortisone excretion is only possible if subjects strictly control their fluid intake and if urine volume is considered an important pre-analytical parameter-otherwise, interpretation of urinary free cortisol results is difficult and of urinary free cortisone data remains tenuous at best.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010401     DOI: 10.1016/j.steroids.2006.08.004

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  8 in total

1.  Late-life depressive symptoms are associated with both hyperactivity and hypoactivity of the hypothalamic-pituitary-adrenal axis.

Authors:  Martin Fenske
Journal:  Am J Geriatr Psychiatry       Date:  2007-11       Impact factor: 4.105

2.  Licorice-induced apparent mineralocorticoid excess compounded by excessive use of terbutaline and high water intake.

Authors:  Laust Frisenberg Buhl; Frederik Nørregaard Pedersen; Marianne Skovsager Andersen; Dorte Glintborg
Journal:  BMJ Case Rep       Date:  2018-04-19

3.  The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndrome.

Authors:  Valentina Guarnotta; Marco C Amato; Rosario Pivonello; Giorgio Arnaldi; Alessandro Ciresi; Laura Trementino; Roberto Citarrella; Davide Iacuaniello; Grazia Michetti; Chiara Simeoli; Annamaria Colao; Carla Giordano
Journal:  Endocrine       Date:  2016-03-10       Impact factor: 3.633

Review 4.  Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing's Syndrome.

Authors:  Lynnette K Nieman
Journal:  Endocr Rev       Date:  2022-09-26       Impact factor: 25.261

5.  Pre-analytical requirements.

Authors:  John H Livesey; M Jane Ellis; Margaret J Evans
Journal:  Clin Biochem Rev       Date:  2008-08

6.  Investigation of possible underlying mechanisms behind water-induced glucose reduction in adults with high copeptin.

Authors:  Sofia Enhörning; Tiphaine Vanhaecke; Alberto Dolci; Erica T Perrier; Olle Melander
Journal:  Sci Rep       Date:  2021-12-29       Impact factor: 4.379

7.  Reduced cortisol metabolism during critical illness.

Authors:  Eva Boonen; Hilke Vervenne; Philippe Meersseman; Ruth Andrew; Leen Mortier; Peter E Declercq; Yoo-Mee Vanwijngaerden; Isabel Spriet; Pieter J Wouters; Sarah Vander Perre; Lies Langouche; Ilse Vanhorebeek; Brian R Walker; Greet Van den Berghe
Journal:  N Engl J Med       Date:  2013-03-19       Impact factor: 91.245

8.  High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension.

Authors:  Giacomo Rossitto; Giuseppe Maiolino; Silvia Lerco; Giulio Ceolotto; Gavin Blackburn; Sheon Mary; Giorgia Antonelli; Chiara Berton; Valeria Bisogni; Maurizio Cesari; Teresa Maria Seccia; Livia Lenzini; Alessio Pinato; Augusto Montezano; Rhian M Touyz; Mark C Petrie; Ronan Daly; Paul Welsh; Mario Plebani; Gian Paolo Rossi; Christian Delles
Journal:  Cardiovasc Res       Date:  2021-04-23       Impact factor: 10.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.